Clinical Trials Logo

Aged clinical trials

View clinical trials related to Aged.

Filter by:

NCT ID: NCT06047522 Recruiting - Virtual Reality Clinical Trials

Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders

APATHIE_RV
Start date: January 3, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to verify that virtual reality is tolerably compatible with apathetic pathologies in patients and residents with major neurocognitive disorders. The main questions it aims to answer are: - Does virtual reality have an impact on symptoms of apathy in the elderly? - Is virtual reality well tolerated by the elderly? Participants will benefit from a 3-session virtual reality headset program with a healthcare professional. They will have one session per week for 3 weeks. They will be observed by another professional, who will complete observation grids on apathy, engagement in activity and tolerance of the virtual reality headset. There is not a comparison group: Researchers will compare the scores before and after the intervention: the participant will be his own control.

NCT ID: NCT06046885 Recruiting - Aged Clinical Trials

Electrical Stimulation in Older Adults

Start date: June 20, 2023
Phase: N/A
Study type: Interventional

Within the problems associated with population aging and its morbidities, the musculoskeletal system is involved in detrimental changes, compromising, in many cases, the functional capacity of the patient and their correct performance in the activities of daily living. Gait and stability are central axes to analyze and enhance in the elderly patient. Strategies for magnify these qualities are innumerable, although active exercise and electrostimulation comprise the most scientifically developed. Therefore, the objective of this study is to evaluate the effects of an electrostimulation (EE) program applied to the triceps surae in older adults on the temporo-spatial parameters of gait, stability and function.

NCT ID: NCT05875623 Recruiting - Aged Clinical Trials

Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults

Start date: July 6, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to assess the effectiveness of a pharmacist-led medication review using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults (MALPIP), an explicit criteria in hospitalized older adults. The main questions it aims to answer are: 1. The effectiveness of the intervention in reducing the number of PIMs and chronic medications after discharge 2. The impact of the intervention on quality of life, falls events, emergency department visits, readmissions and survivals Researchers will compare the control group to see if there is corresponding changes to the outcomes specified above.

NCT ID: NCT05875597 Recruiting - Sarcopenia Clinical Trials

Detection of Clinical-functional Changes Following Exercise Therapy and Neuroscience Education in Institutionalised and Community-dwelling Older Adults Diagnosed With Sarcopenia

Start date: March 2, 2023
Phase: N/A
Study type: Interventional

Nowadays, ageing is an important aspect to consider from a social, healthcare and economic perspective. For this reason, it is necessary to focus on all the elements which can help staying healthy and active in old age. Physical activity and exercise are one of these, and more specifically resistance training.

NCT ID: NCT05834790 Completed - Aged Clinical Trials

Effectiveness of Mobile Augmented Reality (MAR) on Oral Healthcare Education for the Independent Elderly

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn the outcomes of Mobile Augmented Reality (MAR) for oral health education program in the independent elderly. The main question it aims to answer is: • Can MAR for oral health education program provide better outcomes comparing to lecture-based education program and no intervention group. The activity centers from the list will be randomly chosen and assigned to MAR, lecture, and no intervention groups. - Participants from activity centers that were assigned as MAR and lecture groups will attend one time education program. They have to finish questionnaires 3 times and receive 2 times oral examination. - Participants from activity centers that was assigned as no intervention group will not attend any education program. They have to finish questionnaires 2 times and receive 2 times oral examination.

NCT ID: NCT05834569 Recruiting - Delirium Clinical Trials

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Start date: June 15, 2023
Phase: Phase 4
Study type: Interventional

The primary aim of this interventional study is to investigate the impact of perioperative administration of Maxigesic (combination of acetaminophen and ibuprofen) on delirium after minimally invasive lung surgery in elderly patients. The Maxigesic group receives a total of 5 doses of Maxigesic (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthesia induction. The control group receives the same volume of normal saline. Researchers compare the incidence and severity of postoperative delirium for 5 days after surgery.

NCT ID: NCT05808426 Completed - Aged Clinical Trials

Benefits of Online Mahjong by Older Adults

Start date: July 28, 2020
Phase: N/A
Study type: Interventional

This study aims to examine the clinical efficacy of online Mahjong in improving physical health, cognitive performance, happiness, laboratory biomarkers, and structural brain imaging (magnetic resonance imaging, MRI) by a randomized controlled trial design, and hopefully to expand the scope of healthy aging intervention activities with strong scientific evidence.

NCT ID: NCT05808348 Completed - Pain Clinical Trials

Effects of COVID-19 on the Elderly

COVID-19
Start date: March 2, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about in former COVID-19 patients. The main questions it aims to answer are: - are there any association among pain, fear of falling, fall frequency, and physical activity level - are there any difference between former COVID-19 elders and non-COVID-19 elderly population

NCT ID: NCT05807568 Recruiting - Aged Clinical Trials

MIStreatment Screening in Elders Before Discharge

MISSED
Start date: April 10, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the feasibility of introducing, implementing, and integrating a brief, existent elder mistreatment screening tool (the National Collaboratory to Address Elder Mistreatment (NCAEM)'s Elder Mistreatment - Screening And Response Tool (EM-SART) Pre-Screen) in the Memorial Herman Hospital (MHH)-Texas Medical Center (TMC)Acute Care of Elders(ACE) (MHH-TMC ACE) unit and to identify older adults who may already be suffering from abuse, neglect, and/or financial exploitation, as well as connecting the study participants to the primary Geriatric Medicine team on the ACE unit such that additional care, evaluation (including additional in-depth mistreatment screening), and intervention can be taken to prevent and minimize further harm prior to discharge. The investigators hope to reduce missed opportunities for mistreatment detection to lead to safer health outcomes and hospital discharges.

NCT ID: NCT05790720 Not yet recruiting - Aged Clinical Trials

Development of a Pharmacodynamic Model for Propofol in Older Adults

DROPLET
Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this pharmacodynamic study is to develop a model for Propofol administration for older adults (>65 years). The main objective is to create a model based on a new pharmacodynamic parameter, derived from frontal electroencephalogram (EEG), to admininster Propofol in older adults. With this new model, the investigators aim to: - Evaluate the relationship between the plasmatic concentration, described by the Eleveld pharmacokinetic model, versus the effect of the drug represented with a new parameter derived from the intraoperative frontal EEG. - To validate the predictive ability of Eleveld's pharmacokinetic-pharmacodynamic model, based on the bispectral index (BIS), compared to the new model based on a parameter derived from intraoperative frontal EEG. Participants will be asked to answer preoperative questionnaires, receive a Propofol intravenous infusion concomitantly with continuous BIS and EEG monitoring, and to be evaluated for clinical sings of loss and return of consciousness.